Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 Giugno;59(2)

ULTIMO FASCICOLOTHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Rivista di Medicina Nucleare e Imaging Molecolare


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


Periodicità: Trimestrale

ISSN 1824-4785

Online ISSN 1827-1936


eTOC

 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 Giugno;59(2)

 EDITORIAL 25 YEARS OF IMMUNOSCINTIGRAPHY AND THERAPY WITH IRIST 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 Giugno;59(2):137-9

The long history of the International Research Group in Immuno-Scintigraphy and Therapy (IRIST)

Chatal J. F., Perkins A. C., Baum R. P., Bischof Delaloye A., Prior J., Signore A.


 REVIEWS 25 YEARS OF IMMUNOSCINTIGRAPHY AND THERAPY WITH IRIST 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 Giugno;59(2):140-51

The imaging of neuroendocrine tumors using single photon emission computed tomography/computed tomography

Upadhyay B., Lu S.-J., Navalkissoor S., Gnanasegaran G., Buscombe J.


 REVIEWS 25 YEARS OF IMMUNOSCINTIGRAPHY AND THERAPY WITH IRIST 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 Giugno;59(2):152-60

GLP-1 and exendin-4 for imaging endocrine pancreas. A review. Labelled glucagon-like peptide-1 analogues: past, present and future

Hubalewska-Dydejczyk A., Sowa-Staszczak A., Tomaszuk M., Stefańska A.


 REVIEWS 25 YEARS OF IMMUNOSCINTIGRAPHY AND THERAPY WITH IRIST 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 Giugno;59(2):161-7

Which radionuclide, carrier molecule and clinical indication for alpha-immunotherapy?

Guerard F., Barbet J., Chatal J.-F., Kraeber-Bodere F., Cherel M., Haddad F.


 REVIEWS 25 YEARS OF IMMUNOSCINTIGRAPHY AND THERAPY WITH IRIST 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 Giugno;59(2):168-83

New approaches for imaging and therapy of solid cancer

Sollini M., Boni R., Traino A. C., Lazzeri E., Pasqualetti F., Modeo L., Mariani G., Petrini M., Erba P. A.


 REVIEWS 25 YEARS OF IMMUNOSCINTIGRAPHY AND THERAPY WITH IRIST 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 Giugno;59(2):184-96

New approaches to image thyroid cancer cells and microenvironment

Galli F., Iodice V., Lauri C., Signore A.


 REVIEWS 25 YEARS OF IMMUNOSCINTIGRAPHY AND THERAPY WITH IRIST 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 Giugno;59(2):197-213

SPECT radiopharmaceuticals for imaging chronic inflammatory diseases in the last decade

Anzola L. K., Galli F., Dierckx R. A.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 Giugno;59(2):214-9

Using PET-CT in the restaging of primitive mediastinal B-cell lymphoma (PMBCL) after chemotherapy: which criteria should we use?

Giunta F., Zotta M., Menga M., Balma M., Bellò M., Passera R., Filippi A. R., Chiappella A., Ladetto M., Ricardi U., Vitolo U., Bisi G.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 Giugno;59(2):220-7

18F-FDG SPECT/CT in the diagnosis of differentiated thyroid carcinoma with elevated thyroglobulin and negative iodine-131 scans

Ma C., Wang X., Shao M., Zhao L., Jiawei X., Wu Z., Wang H.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 Giugno;59(2):228-37

Targeted ED-B fibronectin SPECT in vivo imaging in experimental atherosclerosis

Dietrich T., Berndorff D., Heinrich T., Hucko T., Stepina E., Hauff P., Dinkelborg L. M., Atrott K., Giovannoni L., Neri D., Fleck E., Graf K., Menssen H. D.


inizio pagina